Skip to content
healthcare.dev

Chlorzoxazone

NDC 51862-339, chlorzoxazone, tablet, from Mayne Pharma Commercial LLC.

Product NDC
51862-339
Status
Listed
Labeler
Mayne Pharma Commercial LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211849
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51862-339 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORZOXAZONE500 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
51862-339-0151862033901100 TABLET in 1 BOTTLE (51862-339-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5238c99e-d36e-4376-ab05-ca2535213d58

Use it

Look up 51862-339 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51862-339 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51862-339. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.